Skip to main content

Table 2 Primary and secondary outcomes

From: Oxytocin versus a combination of tranexamic acid and ethamsylate in reducing intraoperative bleeding during abdominal myomectomy: a randomized clinical trial

  

Oxytocin

Tranexamic acid and ethamsylate

Saline

P value

Blood loss (ml)

Mean (SD)

666.25 (183.03)

630.72 (145.83)

646.67 (168.92)

0.506

Postoperative HB (g%)

Mean (SD)

8.92 (1.25)

9.12 (1.23)

9.07 (1.33)

0.670

Postoperative HCT (%)

Mean (SD)

26.5 (4.81)

26.88 (3.92)

26.45 (4.53)

0.828

Postoperative towels' weights (mg)

Mean (SD)

509.25 (112.2)

496.87 (102.57)

505.72 (108.84)

0.811

Postoperative suction bottle weight (mg)

Mean (SD)

557 (83.39)

533.85 (77.49)

540.95 (84.02)

0.286

Operative time (minutes)

Mean (SD)

65.67 (19.95)

63.08 (18.39)

64.92 (20.51)

0.760

Postoperative Hospital stay (days)

Mean (SD)

2.3 (2.17)

2.33 (2.15)

2.27 (2.18)

0.986

Postoperative wound infection

Yes

12 (20%)

12 (20%)

12 (20%)

1

Postoperative fever

Yes

12 (20%)

14 (23.3%)

10 (16.7%)

0.659

Need to hysterectomy

Yes

0

0

0

Intra or Postoperative blood transfusion

Yes

13 (21.7%)

9 (15%)

12 (20%)

0.624

Postoperative parenteral iron transfusion

Yes

12 (20%)

13 (21.7%)

11 (18.3%)

0.901

  1. Represents outcomes values among groups, continuous values are presented as mean (SD), while dichotomous values are presented as number (percentage)
  2. HB Hemoglobin, and HCT Hematocrit